Stago Group News

New Practical Manual on Hemostasis and Thrombosis in special patient populations

This new book is dedicated to the challenges of hemostasis and thrombosis in special patient populations, offering practical guidance for interpreting test results and improving patient care.

Read more

Stago at the 33rd Annual Congress of the ISTH in Washington, DC

The 33rd Annual Congress of the ISTH (International Society on Thrombosis and Hemostasis) was held in Washington, DC, bringing together thousands of hemostasis specialists from around the world.

Read more

QUALIblood: Our new partner in advancing the diagnosis of thrombosis risk

On 14 February 2025, QUALIblood and Diagnostica Stago formalised a strategic alliance focused on the development and future launch of a new reagent kit, nAPCsr – a thrombin generation test designed to assess thrombosis risk in women considering or currently using oestrogen-based hormonal treatments, particularly oral contraceptives.

Read more

A new look for Stago's scientific posters 

Sharing and deepening knowledge is essential if we are to become a benchmark in the field of blood diagnostics. With this in mind, six scientific posters have been updated and redesigned to offer more up-to-date and accurate content.

Read more

Stago's 2024 CSR report is online

The Stago Group is strengthening its commitment to Corporate Social Responsibility (CSR) and publishing its first 2024 report. 

Read more